Anuh Pharma Ltd

Anuh Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend, reflecting a complex interplay of technical indicators. Despite a 4.34% gain on 15 Jun 2026, the micro-cap pharmaceutical stock continues to face mixed signals from key momentum and trend indicators, underscoring the challenges investors face in navigating its near-term outlook.

Anuh Pharma Ltd (Stock ID: 905552) has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend across multiple timeframes. Despite a micro-cap status and a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s price action and technical parameters warrant close examination for investors navigating the Pharmaceuticals & Biotechnology sector.

Anuh Pharma Ltd has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, as reflected in recent market data and technical indicators. Despite a modest day gain of 2.62%, the stock’s broader technical signals present a complex picture, with mixed readings from MACD, RSI, moving averages, and other momentum oscillators, suggesting cautious investor sentiment amid ongoing volatility.

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 09 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Recent technical indicators including MACD, RSI, Bollinger Bands, and moving averages signal increasing downside pressure, while mixed signals from KST and Dow Theory add complexity to the stock’s near-term outlook.

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day decline of 0.23%, the stock’s technical indicators reveal a complex picture with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism tempered by underlying weaknesses.

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid sector dynamics and peer comparisons, with key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios signalling a recalibration of price attractiveness.

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Feb 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Strong Sell to a Sell rating by MarketsMOJO reflects deteriorating technical conditions, as price momentum weakens and moving averages turn negative. This article analyses the latest technical parameters, price action, and relative performance against the Sensex to provide a comprehensive view for investors.

Anuh Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite recent share price declines and sector headwinds. This change reflects a recalibration of price-to-earnings and price-to-book value metrics relative to historical averages and peer comparisons, offering investors a fresh perspective on the micro-cap pharmaceutical player’s market appeal.

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a modest decline in its share price, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals, reflecting cautious investor sentiment amid broader market pressures.

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a modest day gain of 1.07%, the stock’s technical indicators present a complex picture, with some weekly signals turning mildly bullish while monthly trends remain cautious. This analysis delves into the recent technical parameter changes, evaluating key momentum indicators such as MACD, RSI, moving averages, and others to provide a comprehensive view of the stock’s near-term outlook.

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, a rating that was last updated on 04 February 2026. While this rating change occurred in early February, the analysis and financial metrics presented here reflect the stock's current position as of 01 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.